Trade Artelo Biosciences, Inc. - ARTL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.04 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.09 |
| Open | 1.1 |
| 1-Year Change | -14.06% |
| Day's Range | 1.01 - 1.1 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 23, 2025 | 1.02 | -0.08 | -7.27% | 1.10 | 1.10 | 0.99 |
| Apr 22, 2025 | 1.09 | 0.15 | 15.96% | 0.94 | 1.13 | 0.91 |
| Apr 21, 2025 | 0.92 | 0.03 | 3.37% | 0.89 | 0.95 | 0.87 |
| Apr 17, 2025 | 0.92 | 0.05 | 5.75% | 0.87 | 0.93 | 0.87 |
| Apr 16, 2025 | 0.91 | 0.04 | 4.60% | 0.87 | 0.94 | 0.87 |
| Apr 15, 2025 | 0.97 | 0.09 | 10.23% | 0.88 | 1.01 | 0.86 |
| Apr 14, 2025 | 0.91 | -0.10 | -9.90% | 1.01 | 1.38 | 0.82 |
| Apr 11, 2025 | 0.83 | 0.04 | 5.06% | 0.79 | 0.83 | 0.79 |
| Apr 10, 2025 | 0.82 | 0.02 | 2.50% | 0.80 | 0.82 | 0.80 |
| Apr 9, 2025 | 0.79 | -0.05 | -5.95% | 0.84 | 0.84 | 0.79 |
| Apr 8, 2025 | 0.85 | -0.03 | -3.41% | 0.88 | 0.88 | 0.84 |
| Apr 7, 2025 | 0.86 | 0.02 | 2.38% | 0.84 | 0.86 | 0.79 |
| Apr 4, 2025 | 0.85 | -0.03 | -3.41% | 0.88 | 0.88 | 0.83 |
| Apr 3, 2025 | 0.89 | 0.05 | 5.95% | 0.84 | 0.89 | 0.83 |
| Apr 2, 2025 | 0.86 | 0.05 | 6.17% | 0.81 | 0.87 | 0.81 |
| Apr 1, 2025 | 0.84 | -0.01 | -1.18% | 0.85 | 0.85 | 0.83 |
| Mar 31, 2025 | 0.86 | -0.04 | -4.44% | 0.90 | 0.91 | 0.83 |
| Mar 28, 2025 | 0.92 | -0.02 | -2.13% | 0.94 | 0.94 | 0.90 |
| Mar 27, 2025 | 0.93 | -0.01 | -1.06% | 0.94 | 0.94 | 0.93 |
| Mar 26, 2025 | 0.94 | 0.00 | 0.00% | 0.94 | 0.94 | 0.94 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Artelo Biosciences, Inc. Company profile
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.| Industry: | Bio Therapeutic Drugs |
505 Lomas Santa Fe, Suite 160
92075
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com